This issue brief highlights the extraordinary return on investment from U.S. support for the Global Fund. The brief illustrates how, as an innovative public-private partnership, the Global Fund is challenging the status quo in the way the world fights disease, saving millions of lives, and producing economic, security and humanitarian gains for the U.S. in the process.
If the European Financial Transaction Tax (FTT) is used to finance solidarity projects, it could be a stepping stone towards ending major pandemics such as AIDS. Through an enhanced cooperation procedure, the leaders of 10 countries must make a collective commitment to allocating a significant share of the European Financial Transaction Tax revenues to development, adaptation to climate change and global health such as the fight against pandemics like AIDS.
Publisher: Action against AIDS/Aktionsbündnis gegen AIDS
This report attempts to objectively evaluate the German Government’s contribution in the light of global challenges and agreements and, on this basis, present recommendations for appropriate approaches of political action.
Since 2002, the Global Fund to Fight AIDS, Tuberculosis and Malaria estimates that it has saved 17 million lives and is on course to reach 22 million lives saved by the end of 2016.
The opportunities for continued and greater progress are many. The Global Fund is now engaged in its Fifth Replenishment process and has set a goal of raising a minimum USD$13 billion to meet its targets over the coming three years. In preparation for the Replenishment, the Global Fund developed an Investment Case that describes those targets, what can be accomplished if the targets are met and what the costs would be.
The focus of this document is to examine the cost of inaction if governments do not commit the estimated resource levels needed to meet the 2020 and 2030 targets to end the HIV, TB and malaria epidemics.
The failure to commit the required resources now will not only undermine the strong progress made to date by the Global Fun...
MSF’s report explores the causes of the treatment gap in a vast region comprising 25 countries, with detailed case studies on three contexts: Central African Republic, Democratic Republic of Congo and Guinea. MSF’s report finds that in West and Central Africa needs are underestimated and little priority is given to HIV as a health issue in the region. The route to obtaining HIV treatment is an obstacle course for people living with HIV with barriers such as stigma, stock outs of diagnostics and drugs, patient fees, and unaffordable, burdensome and poor quality services. Recurrent crises following violence or epidemics compound already existing challenges to accessing HIV care. The report recommends major changes in policies and models of care reflecting both lessons learned from progress in the fight against HIV elsewhere as well as innovative approaches specially tailored to contexts with low ART coverage.
The latest survey finds that a majority of the public wants the U.S. to take either the leading role or a major role in trying to solve international problems generally, as well as in improving health for people in developing countries specifically.
When asked how funds should be directed, a majority of the public thinks the U.S. should give money to international organizations like the Global Fund to Fight Aids, Tuberculosis and Malaria (77 percent), the United Nations and the World Health Organization (71 percent), or directly to U.S. based non-profits operating programs in developing countries (65 percent).